Markus Puhlmann
At a glance: Markus Puhlmann is Chief Medical Officer at Perspective Therapeutics (CATX). Their latest SEC Form 4, filed Nov 13, 2026, reported a purchase of $5K. On file: 2 purchase lines ($35K) and 0 sale lines ($0).
Disclosed holdings: about $168K of CATX stock: 178,542 shares reported on their latest Form 4 (filed Nov 13, 2026), valued at the Nov 13, 2026 close of $0.94. This counts only CATX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Chief Medical Officer at Perspective Therapeutics, Inc. (CATX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Every purchase since 2023
From the SEC's insider data sets: each open-market buy by Markus Puhlmann, matched to how the stock did over the next 90 days against the S&P 500.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 13 NewSEC | CATXPerspective Therapeutics, Inc.First buy in 2 yrsPast buys 2/2 beat S&P | Buy | 6,000143,542 held (+4%) | $0.83 | $5K | +13.3% |
| Nov 13 NewSEC | CATXPerspective Therapeutics, Inc.First buy in 2 yrsPast buys 2/2 beat S&P | Buy | 35,000178,542 held (+24%) | $0.84 | $30K | +11.3% |
- Buy
Chief Medical Officer Markus Puhlmann bought $5K of CATX at $0.83 — first open-market purchase in our records.
- Buy
Chief Medical Officer Markus Puhlmann bought $30K of CATX at $0.84 — largest purchase by this insider in our records; raises the stake by 24%.
Follow Markus Puhlmann
Get one email when Markus Puhlmann files a new purchase or sale. Free.
At most one email a day about Markus Puhlmann, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.